REALiTEC cohort 2: teclistamab shows favorable real-world outcomes in R/R myeloma
Rakesh Popat, MBBS, MRCP, FRCPath, PhD, University College London Hospitals, London, UK, presents data from cohort 2 of the REALiTEC study (NCT06285318) evaluating the real-world use of teclistamab...
vjhemonc.com